D. Hanahan and R. Weinberg, The hallmarks of cancer, Cell, vol.100, issue.1, pp.81683-81692, 2000.

D. Hanahan and R. Weinberg, The hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011.

L. Ding, G. Getz, D. A. Wheeler, E. R. Mardis, M. D. Mclellan et al., Somatic mutations affect key pathways in lung adenocarcinoma, Nature, vol.455, issue.7216, pp.1069-1075, 2008.

R. D. Morin, M. Mendez-lago, A. J. Mungall, R. Goya, K. L. Mungall et al., Frequent mutation of histone modifying genes in non-Hodgkin lymphoma, Nature, vol.476, issue.7360, pp.298-303, 2012.

J. G. Paez, P. A. Jä-nne, J. C. Lee, S. Tracy, H. Greulich et al., EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy, Science, vol.304, issue.5676, pp.1947-1500, 2004.

G. M. Cooper, The cell: a molecular approach, 2000.

P. L. Chen, Y. M. Chen, R. Bookstein, and L. W. , Genetic mechanisms of tumor suppression by the human p53 gene, Science, vol.250, issue.4987, pp.1576-1580, 1990.

M. L. Gemignani, A. C. Schlaerth, F. Bogomolniy, R. R. Barakat, O. Lin et al., Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma, Gynecol Oncol, pp.378-381, 2003.

A. L. Schechter, D. F. Stern, L. Vaidyanathan, S. J. Decker, J. A. Drebin et al., The neu oncogene: an erb-B-related gene encoding an 185,000-M tumor antigen, Nature, vol.312, pp.513-516, 1984.

C. A. Hudis, Trastuzumab-mechanism of action and use in clinical practice, N Engl J Med, vol.357, issue.1, pp.39-51, 2007.

P. Futreal, L. Coin, M. Marshall, T. Down, T. Hubbard et al., A census of human cancer genes, Nat Rev Cancer, vol.4, pp.177-183, 2004.

J. N. Weinstein, E. A. Collisson, G. B. Mills, K. M. Shaw, B. A. Ozenberger et al., The Cancer Genome Atlas Pan-Cancer Analysis Project Nature Genet, vol.45, pp.1113-1120, 2013.

J. Zhang, J. Baran, A. Cros, J. M. Guberman, S. Haider et al., International Cancer Genome Consortium Data Portal-a one-stop shop for cancer genomics data, Database (Oxford), 2011.

S. A. Forbes, D. Beare, H. Boutselakis, S. Bamford, and N. Bindal, COSMIC: somatic cancer genetics at high-resolution, Nucleic Acids Res, vol.45, pp.777-783, 2017.

B. Vogelstein, N. Papadopoulos, V. E. Velculescu, S. Zhou, L. A. Diaz et al., Cancer Genome Landscapes. Science, vol.339, issue.6127, pp.1546-1558, 2013.

M. Lawrence, P. Stojanov, P. Polak, G. V. Kryukov, K. Cibulkis et al., Mutational heterogeneity in cancer and the search for new cancer associated genes, Nature, vol.499, pp.214-218, 2013.

, The Cancer Genome Atlas Research Network Comprehensive genomic characterization of squamous cell lung cancers, Nature, vol.7417, pp.519-52, 2012.

L. Alexandrov, S. Nik-zainal, D. Wedge, S. Aparicio, S. Behjati et al., Signatures of mutational processes in human cancer, Nature, vol.500, pp.415-421, 2013.

N. D. Dees, Q. Zhang, C. Kandoth, M. C. Wendl, W. Schierding et al., Identifying mutational significance in cancer genomes, Genome Res, vol.22, issue.8, pp.1589-1598, 2012.

J. Reimand and G. Bader, Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers, Mol Syst Biol, vol.9, p.637, 2013.

M. S. Lawrence, P. Stojanov, C. H. Mermel, J. T. Robinson, L. A. Garraway et al., Discovery and saturation analysis of cancer genes across 21 tumor types, Nature, vol.505, issue.7484, pp.495-501, 2014.

A. Gonzalez-perez and N. Lopez-bigas, Functional impact bias reveals cancer drivers, Nucleic Acids Res, vol.40, issue.21, 2012.

A. Bashashati, G. Haffari, J. Ding, G. Ha, K. Lui et al., DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer, Genome Biol, vol.13, issue.12, p.124, 2012.

M. H. Bailey, C. Tolkheim, E. Porta-pardo, S. Sengupta, D. Bertrand et al., Comprehensive characterization of cancer driver genes and mutations, Cell, vol.173, pp.371-385, 2018.

I. F. Chung, C. Y. Chen, S. C. Su, C. Y. Li, K. J. Wu et al., DriverDBv2: a database for human cancer driver gene research, Nucleic Acids Res, vol.44, issue.D1, pp.975-984, 2016.

T. Davoli, A. Xu, K. Mengwasser, L. Sack, J. Yoon et al., Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome, Cell, vol.155, issue.4, pp.948-962, 2013.

G. E. Melloni, A. G. Ogier, S. De-pretis, L. Mazzarella, M. Pelizzola et al., DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomes, Genome Med, vol.6, issue.6, p.44, 2014.

C. J. Tokheim, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, and R. Karchin, Evaluating the evaluation of cancer driver genes, Proc Natl Acad Sci U S A, vol.113, issue.50, pp.14330-14335, 2016.

J. Barretina, G. Caponigro, N. Stransky, K. Venkatesan, A. A. Margolin et al., The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, vol.483, issue.7391, pp.603-610, 2012.

B. Schö, Kernel methods in computational biology, 2004.

M. D. Leiserson, F. Vandin, H. Wu, J. R. Robson, J. V. Eldridge et al., Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes, Nature Genetics, vol.47, pp.106-114, 2015.

A. Cho, J. E. Shim, E. Kim, F. Supek, B. Lehner et al., MUFFINN: cancer gene discovery via network analysis of somatic mutation data, Genome Biology, vol.17, p.27333808, 2016.

T. Evgeniou, C. Micchelli, and M. Pontil, Learning multiple tasks with kernel methods, J Mach Learn Res, vol.6, pp.615-637, 2005.

F. Mordelet and J. Vert, ProDiGe: Prioritization Of Disease Genes with multitask machine learning from positive and unlabeled examples, BMC Bioinformatics, vol.12, issue.1, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00594774

P. F. Przytycki and M. Singh, Differential analysis between somatic mutation and germline variation profiles reveals cancer-related genes, Genome Medicine, p.28841835, 2017.

T. Frixa, A. Sacconi, M. Cioce, G. Roscilli, F. F. Ferrara et al., MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration, Carcinogenesis, vol.39, issue.2, pp.293-304, 2018.

S. B. Talla and F. H. Brembeck, The role of Pygo2 for Wnt-catenin signaling activity during intestinal tumor initiation and progression, Oncotarget, vol.7, issue.49, pp.80612-80644, 2016.

R. R. Bhanvadia, C. Vanopstall, H. Brechka, N. S. Barashi, M. Gillard et al., MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease, Clinical Cancer Research, vol.1, issue.15, pp.3668-80, 2018.

T. Hara, M. Schwieger, R. Kazama, S. Okamoto, K. Minehata et al., Acceleration of chronic myeloproliferation by enforced expression of Meis1 or Meis3 in Icsbp-deficient bone marrow cells, Oncogene, vol.27, issue.27, pp.3865-3874, 2008.

S. Mohr, C. Doebele, F. Comoglio, T. Berg, J. Beck et al., Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia, Cancer Cell, vol.31, issue.4, pp.549-562, 2017.

M. Presta, P. Chiodelli, A. Giacomini, M. Rusnati, and R. Ronca, Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach, Pharmacology and Therapeutics, vol.179, pp.171-187, 2017.

E. A. Kim, Y. H. Kim, H. W. Kang, H. Y. Yoon, W. T. Kim et al., Lower Levels of Human MOB3B Are Associated with Prostate Cancer Susceptibility and Aggressive Clinicopathological Characteristics, Journal of Korean Medical Science, vol.30, issue.7, pp.937-979, 2015.

Y. W. Hu, Z. P. Chen, X. M. Hu, J. Y. Zhao, J. L. Huang et al., The miR-573/apoM/Bcl2A1-dependent signal transduction pathway is essential for hepatocyte apoptosis and hepatocarcinogenesis, Apoptosis, vol.20, issue.10, pp.1321-1358, 2015.

Y. K. Chae, J. F. Anker, B. A. Carneiro, S. Chandra, J. Kaplan et al., Genomic landscape of DNA repair genes in cancer, Oncotarget, vol.7, issue.17, pp.23312-23333, 2016.

A. Torgovnick and B. Schumacher, DNA repair mechanisms in cancer development and therapy, Front Genet, vol.6, 2015.

J. Genschel, L. R. Bazemore, and P. Modrich, Human exonuclease I is required for 5' and 3' mismatch repair, J Biol Chem, vol.277, pp.13302-13313, 2002.

M. Manandhar, K. S. Boulware, and R. D. Wood, The ERCC1 and ERCC4 (XPF) genes and gene products, Gene, vol.569, issue.2, pp.153-161, 2015.

M. Okuda, . Nakazawa, C. Guo, T. Ogi, and Y. Nishimura, Common TFIIH recruitment mechanism in global genome and transcription-coupled repair subpathways, Nucleic Acids Res, vol.45, issue.22, pp.13043-55, 2017.

H. Zhou, Y. Qin, S. Ji, J. Ling, J. Fu et al., SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer, Oncogene, vol.37, issue.7, pp.912-935, 2018.

A. Salmaninejad, V. Khoramshahi, A. Azani, E. Soltaninejad, S. Aslani et al., PD-1 and cancer: molecular mechanisms and polymorphisms, Immunogenetics, vol.70, issue.2, pp.73-86, 2018.

F. Casciello, F. Al-ejeh, G. Kelly, D. J. Brennan, S. F. Ngiow et al., G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis, Proceedings of National Academy of Sciences of United States of America, vol.114, pp.7077-82, 2017.

R. Bhatia, S. K. Gautam, A. Cannon, C. Thompson, B. R. Hall et al., Cancer-associated mucins: role in immune modulation and metastasis. Cancer and Metastasis Reviews, 2019.

V. Patil, J. Pal, and K. Somasundaram, Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing, Oncotarget, vol.6, issue.41, pp.43452-71, 2015.

H. Guo, L. Zhao, B. Shi, J. Bao, D. Zheng et al., GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90, Oncogene, vol.1, 2018.

L. Li, M. Peng, Z. Xue, T. Fan, J. Wang et al., Integrated analysis of dysregulated long noncoding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma, Journal of Translational Medicine, vol.27, issue.1, p.372, 2018.

K. Xie, K. Zhang, J. Kong, C. Wang, Y. Gu et al., Cancer-testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma, Cancer Med, vol.7, issue.1, pp.157-166, 2018.

R. Iliev, M. Stanik, M. Fedorko, A. Poprach, P. Vychytilova-faltejskova et al., Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients, OncoTargets and Therapy, vol.9, pp.217-239, 2016.

S. Jitsukawa, R. Kamekura, K. Kawata, F. Ito, A. Sato et al., Loss of sorting nexin 5 stabilizes internalized growth factor receptors to promote thyroid cancer progression, Journal of Pathology, vol.243, issue.3, pp.342-353, 2017.

S. Y. Lin, Y. B. Lv, G. X. Mao, X. J. Chen, and F. Peng, The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer, Oncology Letters, vol.16, issue.5, pp.6721-6729, 2018.

I. L. Hsu, C. Y. Chou, Y. Y. Wu, J. E. Wu, C. H. Liang et al., Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma, Oncotarget, vol.7, issue.39, pp.62925-62963, 2016.

S. Yu, H. Bian, X. Gao, and L. Gui, Annexin A9 promotes invasion and metastasis of colorectal cancer and predicts poor prognosis, Journal of Molecular Medicine, vol.41, issue.4, pp.2185-92, 2018.

C. Lobry, P. Oh, M. R. Mansour, A. T. Look, and I. Aifantis, Notch signaling: switching an oncogene to a tumor suppressor, Blood, vol.123, issue.16, pp.2451-2460, 2014.

A. Hryniuk, S. Grainger, J. G. Savory, and D. Lohnes, Cdx1 and Cdx2 350 function as tumor suppressors, J. Biol. Chem, vol.289, issue.48, pp.33343-54, 2014.

H. Ju, L. Zhang, L. Mao, Y. Wu, S. Liu et al., A comprehensive genome-wide analysis of the long noncoding RNA 353 expression profile in metastatic lymph nodes of oral mucosal melanoma, Gene, vol.675, pp.44-53, 2018.

L. Olsson, S. Zettermark, A. Biloglav, A. Castor, M. Behrendtz et al., The genetic landscape of paediatric de novo acute 356 myeloid leukaemia as defined by single nucleotide polymorphism array and exon 357 sequencing of 100 candidate genes, Br J Haematol, vol.174, issue.2, pp.292-301, 2016.

M. Mehrotra, L. J. Medeiros, R. Luthra, R. L. Sargent, H. Yao et al., Identification of putative pathogenic microRNA and its downstream targets 361 in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma, Hum. Pathol, vol.45, issue.10, 1995.

V. H. Laitinen, T. Rantapero, D. Fischer, E. M. Vuorinen, and T. L. Tammela, PRACTICAL Consortium et al. Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes 365 and sequence variants associated with a genetic predisposition to prostate cancer, Int. J. Cancer, vol.136, issue.10, pp.2316-2343, 2015.

X. Zhou, H. Q. Zhu, C. Q. Ma, H. G. Li, F. F. Liu et al., MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by 373 repressing TNIP2 expression, Biomed. Pharmacother, vol.79, pp.315-335, 2016.

T. Sakoparnig, P. Fried, and N. Beerenwinkel, Identification of constrained cancer driver genes based on mutation timing, PLoS Comput Biol, vol.11, issue.1, p.1004027, 2015.

B. Schö, R. Williamson, A. Smola, J. Shawe-taylor, and J. Platt, Support vector method for novelty detection, Mach Learn Interpret Neuroimaging, pp.582-588, 1999.

R. Vert and J. Vert, Consistency and convergence rates of one-class SVMs and related algorithms, J. Mach. Learn. Res, vol.7, pp.817-54, 2006.

R. I. Kondor and J. Lafferty, Diffusion kernels on graphs and other discrete input spaces, Proc Int Conf Mach Learn, vol.3, pp.315-322, 2002.

L. Cowen, T. Ideker, B. J. Raphael, and R. Sharan, Network propagation: a universal amplifier of genetic associations, Nature Rev Genet, 2017.

T. S. Prassad, R. Goel, K. Kandasamy, S. Keerthimukar, S. Kumar et al., Human Protein Reference Database-2009 update, Nucleic Acids Res, vol.37, pp.767-72, 2009.

A. Karatzoglou, A. Smola, K. Hornik, and A. Zeileis, kernlab-An S4 Package for Kernel Methods in R, J Stat Softw, pp.11-20, 2004.